Wednesday, March 23, 2016 5:40:00 AM PDT | VentureDeal
West Henrietta, New York -- Biotechnology company Adarza BioSystems has received $5 million in its second round of institutional venture capital funding.
Adarza has developed a biological assay platform for measuring clinical and point of care samples. Cultivation Capital led the round, which included previous investors Lewis & Clark Ventures and Siemens Venture Capital. The company said it would use the funding to expand its production capacity and launch its first immunoassay product platform.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
